Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

CA Healthcare Acquisition Corp Cl A (CAHC)

CA Healthcare Acquisition Corp Cl A (CAHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.

LumiraDx Limited (“LumiraDx”), a next-generation point of care (“POC”) diagnostic testing company and CA Healthcare Acquisition Corp. (“CAHC”), a special purpose acquisition company traded...

CAHC : 9.94 (-1.97%)
CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination

CA Healthcare Acquisition Corp. (NASDAQ: CAHC) (“CA Healthcare”), a publicly traded special purpose acquisition company, and LumiraDx Limited (“LumiraDx”), a next-generation point of care diagnostics...

CAHC : 9.94 (-1.97%)
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics

Today, LumiraDx, a next-generation point of care diagnostics testing company, and CA Healthcare Acquisition Corp (Nasdaq: CAHC), a special purpose acquisition company focused on investing in a growth-oriented...

CAHC : 9.94 (-1.97%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of CAHC, CADE, GNPK, and FTCV Mergers

WILMINGTON, Del., July 02, 2021 (GLOBE NEWSWIRE) --

CAHC : 9.94 (-1.97%)
CADE : 33.02 (-0.12%)
GNPK : 10.50 (+4.69%)
FTCV : 10.06 (-0.01%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CA Healthcare Acquisition Corp. Merger

WILMINGTON, Del., April 21, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating CA Healthcare Acquisition Corp. (“CA Healthcare”) (NASDAQ GS: CAHC ) regarding possible...

CAHC : 9.94 (-1.97%)
Moore Kuehn Encourages MUDS, ROT, CAHC, and MCAD Investors to Contact Law Firm

NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning...

MUDS : 10.16 (unch)
MCAD : 10.43 (-4.92%)
ROT : 10.05 (-2.14%)
CAHC : 9.94 (-1.97%)
LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp

CA Healthcare Acquisition Corp (Nasdaq: CAHC), a special purpose acquisition company focused on investing in a growth-oriented healthcare company which recently raised $115 million in its initial public...

CAHC : 9.94 (-1.97%)

Barchart Exclusives

What the Election Results May Mean for the Corn and Soybean Markets
Taking a look at whether the trade war comes back and what it means if it does. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar